News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
6,528 Results
Type
Article (777)
Press Release (5751)
Section
Business (1808)
Career Advice (5)
Deals (406)
Drug Delivery (4)
Drug Development (703)
Employer Resources (1)
FDA (264)
Job Trends (166)
News (3664)
Policy (822)
Tag
Academia (10)
Alliances (365)
Alzheimer's disease (2)
Approvals (267)
Artificial intelligence (5)
Autoimmune disease (2)
Bankruptcy (6)
Best Places to Work (71)
Biosimilars (57)
Cancer (1)
Career advice (4)
Cell therapy (1)
Clinical research (628)
Collaboration (11)
Complete response letters (2)
COVID-19 (18)
C-suite (14)
Data (28)
Denatured (3)
Diabetes (1)
Diagnostics (7)
Digital health (1)
Diversity, equity & inclusion (1)
Drug pricing (10)
Drug shortages (1)
Duchenne muscular dystrophy (2)
Earnings (699)
Editorial (1)
Employer resources (1)
Events (521)
Executive appointments (11)
FDA (288)
Funding (8)
Gene therapy (1)
GLP-1 (11)
Government (98)
Guidances (4)
Healthcare (69)
Huntington's disease (1)
Immunology and inflammation (6)
Indications (2)
Infectious disease (18)
Inflammatory bowel disease (14)
Inflation Reduction Act (1)
Intellectual property (1)
IPO (84)
IRA (3)
Job creations (88)
Job search strategy (4)
JPM (2)
Labor market (6)
Layoffs (25)
Legal (456)
Manufacturing (5)
MASH (2)
Medical device (21)
Medtech (21)
Mergers & acquisitions (327)
Metabolic disorders (7)
mRNA (2)
Multiple sclerosis (4)
Neurodegenerative disease (1)
Neuropsychiatric disorders (1)
Neuroscience (25)
NextGen: Class of 2026 (42)
Non-profit (8)
Now hiring (1)
Obesity (4)
Opinion (8)
Patents (5)
People (719)
Pharmacy benefit managers (2)
Phase 1 (78)
Phase 2 (190)
Phase 3 (351)
Pipeline (58)
Policy (6)
Postmarket research (69)
Preclinical (30)
Prostate cancer (1)
Radiopharmaceuticals (2)
Rare diseases (3)
Real estate (31)
Regulatory (321)
Reports (1)
Research institute (9)
RNA editing (2)
Schizophrenia (12)
Series A (2)
Special edition (1)
Startups (28)
Supply chain (1)
Vaccines (2)
Weight loss (3)
Women's health (1)
Date
Today (1)
Last 7 days (2)
Last 30 days (19)
Last 365 days (150)
2026 (73)
2025 (160)
2024 (265)
2023 (240)
2022 (815)
2021 (584)
2020 (462)
2019 (329)
2018 (328)
2017 (378)
2016 (330)
2015 (516)
2014 (310)
2013 (280)
2012 (259)
2011 (251)
2010 (217)
Location
Africa (13)
Arizona (1)
Asia (1788)
Australia (59)
California (42)
Canada (8)
China (2)
Connecticut (2)
Delaware (1)
Europe (1082)
Florida (10)
Illinois (7)
Indiana (2)
Japan (2)
Maryland (1)
Massachusetts (25)
Minnesota (1)
Missouri (1)
New Jersey (56)
New York (8)
North Carolina (2)
Northern California (23)
Ohio (1)
Pennsylvania (4)
Puerto Rico (1)
Rhode Island (2)
South America (12)
Southern California (15)
Texas (2)
United States (148)
Utah (2)
Washington D.C. (4)
Washington State (3)
Wisconsin (1)
6,528 Results for "teva".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Teva Releases Q2 2026 Aide Memoire
June 19, 2026
·
2 min read
Press Releases
Teva to Present at the Goldman Sachs Global Healthcare Conference
June 2, 2026
·
3 min read
Press Releases
Teva’s Data on AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Highlight Long-Term Advances in Tardive Dyskinesia Treatment and Care
June 8, 2026
·
11 min read
Press Releases
Teva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva’s Pivot to Growth Strategy
April 29, 2026
·
8 min read
Press Releases
The European Medicines Agency Accepts Teva’s Marketing Authorization Application for Olanzapine Long-Acting Injectable (TEV-‘749) for the Treatment of Schizophrenia in Adults
May 21, 2026
·
7 min read
Press Releases
Teva Submits NDA for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Tourette Syndrome
June 19, 2026
·
5 min read
Press Releases
Teva Expands European biosimilars portfolio with launch of AHZANTIVE® (aflibercept) biosimilar to Eylea®
June 4, 2026
·
5 min read
Press Releases
Teva to Present at the BofA Securities Health Care Conference
May 4, 2026
·
3 min read
Press Releases
Fitch Upgrades Teva to Investment Grade Amid Pivot to Growth Execution
May 18, 2026
·
4 min read
Press Releases
Teva’s 2025 Healthy Future Report Highlights Environmental and Access to Medicines Progress, Including Meeting All Sustainability-Linked Bond Targets
April 30, 2026
·
5 min read
1 of 653
Next
